CH
VCSH icon

CVS Health’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

CVS Health’s Portfolio VCSH Stock Details VCSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.48M Hold
120,000
– – 4.21% 8
2026
Q1 		$9.51M Buy
+120,000
New +$9.56M 4.48% 8

Other funds holding VCSH

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $10B AUM 30.74% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.36B AUM 7.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

CVS Health's VCSH Position: Q2 2026 in Review

CVS Health held its Vanguard Short-Term Corporate Bond ETF (VCSH) position steady in Q2 2026 at 120,000 shares worth $9.48M. The position accounts for 4.21% of the portfolio, ranked #8.

CVS Health first reported a position in VCSH in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.51M in Q1 2026. 1,462 funds tracked by Wall St. Rank hold VCSH as of Q2 2026.

  • CVS Health held 120,000 shares of Vanguard Short-Term Corporate Bond ETF worth $9.48M as of Q2 2026.
  • CVS Health left its Vanguard Short-Term Corporate Bond ETF share count unchanged in Q2 2026.
  • Vanguard Short-Term Corporate Bond ETF made up 4.21% of CVS Health's portfolio in Q2 2026, its #8 holding.
  • CVS Health first reported a position in Vanguard Short-Term Corporate Bond ETF in Q1 2026 and has held it in 2 quarters since.
  • CVS Health's Vanguard Short-Term Corporate Bond ETF position peaked at $9.51M in Q1 2026.
  • 1,462 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q2 2026.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.